CLINICAL_TRIALS
trial_result
· 2017-12-19
Clinical Trial Update: Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis [Phase 2]
Summary
Phase 2 pilot trial evaluating ustekinumab for chronic atopic dermatitis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rockefeller University | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-12-19